|
|
|
|
Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
SAN FRANCISCO, July 3 /PRNewswire-USNewswire/ -- Tomorrow, Corey Reich, an ALS patient from Piedmont, California, will attend both the San Francisco Giants and Los Angeles Angels of Anaheim baseball games this July 4th as a representative of...
|
|
|
Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
WATERTOWN, Mass., July 2 /PRNewswire-USNewswire/ -- Last week, physicians, scientists, patients and members of the biotech industry from around the world gathered for the first major meeting of a unique research center on muscular...
|
|
|
US parents think twice about sending kids to camp
-0400 (Reuters Health) By I-Ching Ng NEW YORK (Reuters) - Since its opening last week, camp counselors at New Jersey's Liberty Lake Day Camp disinfect door knobs, take the temperatures of children as they arrive and remind the campers not to...
|
|
|
Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
SAN FRANCISCO 'My hope is that my presence at both games will help to put a new face on this disease by providing a personal connection to ALS,' said Corey.'Although it is an orphan disease, I hope to bring larger public awareness and...
|
|
|
Parents think twice about kids' camps
New York - Since its opening last week, camp counsellors at New Jersey's Liberty Lake Day Camp disinfect door knobs, take the temperatures of children as they arrive and remind the campers not to share canned sodas.Many of the 12 000-plus...
|
|
|
Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
WATERTOWN, Mass., July 2 /PRNewswire-USNewswire/ -- Last week, physicians, scientists, patients and members of the biotech industry from around the world gathered for the first major meeting of a unique research center on muscular...
|
|
|
Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
From the PharmaLive.com News Archive - Jul.02, 2009 WATERTOWN, Mass., July 2 /PRNewswire-USNewswire/ -- Last week, physicians, scientists, patients and members of the biotech industry from around the world gathered for the first major...
|
|
|
Successful Beginning for Wellstone Muscular Dystrophy Center at Boston Biomedical Research Institute
WATERTOWN, Mass., July 2 /PRNewswire-USNewswire/ -- Last week, physicians, scientists, patients and members of the biotech industry from around the world gathered for the first major meeting of a unique research center on muscular...
|
|
|
MPs Debate 'Blatant Discrimination' Of Oyxgen Users, UK
Yesterday MPs debated the discrimination that people with a lung condition can experience when they travel on planes.People with lung conditions such as Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension often require...
|
|
|
Researchers find new evidence for immune-system involvement in ALS
- Researchers in the laboratory of Don Cleveland at the University of California-San Diego have added to a growing body of evidence that implicates the immune system in amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease), the ...
|
|
|
A Case for Immunosuppression for Myoblast Transplantation in Duchenne Muscular Dystrophy
Jacques P Tremblay1, Daniel Skuk1, Benjamino Palmieri2 and David M Rothstein3 1Unit de Recherche en Gntique Humaine, Centre de Recherche du Centre Hospitalier Universitaire de Qubec et Universit Laval, Quebec, Canada 2Department of General...
|
|
|
Platform Screens Cell Lines Derived from Human Embryonic Stem Cells for Muscular Dystrophy Research
Investigators are using a new stem cell screening platform to automate high content screening of small molecules for muscular dystrophy therapeutic research.The research shows the utility of the system in performing automated...
|
|
|
Insmed Presents Result Of Phase-II IPLEX Trial
Trial was intended to treat patients with Myotonic Muscular Dystrophy Related News Cephalon, no longer obligated to make a $15 million milestone payment ...Lestaurtinib, for the treatment of relapsed acute Myelogenous Leukemia...
|
|
|
Medical News: Stem Cell Surprise For Tissue Regeneration
Stem Cell Research News Main Category: Stem Cell Research Also Included In: Rehabilitation / Physical Therapy; Muscular Dystrophy / ALS email to a friend printer friendly view / write opinions rate article Current Article Ratings...
|
|
|
AVI BioPharma, Inc. (AVII) Joining Russell 3000 Index
- (NASDAQ: AVII), a developer of RNA-based drugs, today announced that immediately following the close of the U.S.markets today it will join the broad-market Russell 3000 Index following Russell Investments' annual reconstitution of its...
|
|
|
AVI BioPharma Joining Russell 3000 Index
AVI BioPharma, Inc.(NASDAQ:AVII - News), a developer of RNA-based drugs, today announced that immediately following the close of the U.S. markets today it will join the broad-market Russell 3000 Index following Russell Investments'...
|
|
|
AVI Biopharma to join Russell 3000 Index
Choose Another City: Site| News | Companies | Videos | Jobs Home News Latest News Exclusive Subscriber Content Most Viewed Stories Most Emailed Stories Access Digital Edition Washington Bureau Special Reports News From Other Cities Contact...
|
|
|
AVI BioPharma Joining Russell 3000 Index
AVI BioPharma, Inc.(NASDAQ: AVII), a developer of RNA-based drugs, today announced that immediately following the close of the U.S. markets today it will join the broad-market Russell 3000 Index following Russell Investments' annual...
|
|
|
AVI BioPharma Joining Russell 3000 Index
2009-06-2610:37ET - News Release PORTLAND, OR -- (MARKET WIRE) -- 06/26/09 AVI BioPharma, Inc.(NASDAQ: AVII), a developer of RNA-based drugs, today announced that immediately following the close of the U.S. markets today it will join...
|
|
|
Broad Therapy For Muscular Dystrophy
A group led by Dr.Paul T. Martin of The Ohio State University College of Medicine has demonstrated that the glycosyltransferase Galgt2 can lessen symptoms in multiple models of muscular dystrophy. Their report can be found in...
|
|
|
Broad Therapy For Muscular Dystrophy, Ohio State University Study
' A group led by Dr.Paul T. Martin of The College of Medicine has demonstrated that the glycosyltransferase Galgt2 can lessen symptoms in multiple models of muscular dystrophy. Broad Therapy For Muscular Dystrophy,...
|
|
|
Insmed Announces Results Of IPLEX(TM) Phase II Trial In Myotonic Muscular Dystrophy
Insmed Inc.(Nasdaq: INSM), a biopharmaceutical company, announced results from its exploratory U.S. Phase II clinical trial evaluating IPLEX(TM) (mecasermin rinfabate) in patients with myotonic muscular dystrophy ('MMD'). The...
|
|
|
Insmed Announces Results Of IPLEX™ Phase II Trial In Myotonic Muscular Dystrophy
Insmed to Evaluate Potential Initiation of Phase II Trial for IPLEX in MMD Patients with Severe Insulin Resistance Richmond, VA /PRNewswire-FirstCall/ -- Insmed Inc.(Nasdaq: INSM), a biopharmaceutical company, today announced results from...
|
|
|
Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
- Insmed to Evaluate Potential Initiation of Phase II Trial for IPLEX(TM) in MMD Patients with Severe Insulin Resistance - RICHMOND, Va., June 25 /PRNewswire-FirstCall/ -- Insmed Inc., a biopharmaceutical company, today announced results...
|
|
|
Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
- Insmed to Evaluate Potential Initiation of Phase II Trial for IPLEX(TM) in MMD Patients with Severe Insulin Resistance - RICHMOND, Va., June 25 /PRNewswire-FirstCall/ -- Insmed Inc.The results of the trial indicated that IPLEX(TM) did...
|
